SCHEMBL6530423

SCHEMBL6530423

COC(=O)[C@H](CC(C)C)Nc1nc(NCCc2ccc(OC)cc2)nc(Nc2cccc(F)c2)n1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CNR2 P34972 4/20 0.43
CTSK P43235 1/20 0.42
KCNH3 Q9ULD8 3/20 0.41
FCGR3B O75015 1/20 0.40
FCGR1A P12314 1/20 0.40
FCGR2A P12318 1/20 0.40
MAP2K7 O14733 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
GBA1 P04062 1/20 0.40
CTSS P25774 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6530426 1.00 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6530247 0.93 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6529732 0.89 CA1 (0.52) ALDH1A1
SCHEMBL6529735 0.89 CA1 (0.52) ALDH1A1
SCHEMBL8298689 0.88 CYP2C9 (0.44) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6528805 0.88 CYP2C9 (0.44) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6531002 0.87 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6530084 0.86 RORC (0.45) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6530078 0.86 RORC (0.45) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6529452 0.84 CDC7 (0.44) CYP1A2CYP2C9CYP2C19KCNH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed